Radiopharm Theranostics (RADX) has executed a subscription agreement for a private placement of ordinary shares to Lantheus Holdings (LNTH), ...

Radiopharm Theranostics (RADX) has entered into a strategic co-development partnership with Lantheus (LNTH) to advance the clinical development ...

The placement of 133 million shares was completed at an issue price of A$0.060 per share, representing a 150% premium to the last traded price of RAD shares (A$0.024). Settlement is expected to occur ...

This feature is currently unavailable; we are sorry for the inconvenience to you. Nasdaq Analyst Research provides analyst research for ratings consensus and a summary of stock price targets ...

We've identified the following companies as similar to Radiopharm Theranostics Ltd ADR because they operate in a related industry or sector. We also considered size, growth, and various financial ...

But as more wearable devices come to market for in-hospital or in-home use ... in the National Institutes of Health Rapid Acceleration of Diagnostics Technology (RADx Tech) for Maternal Health ...

A highlight of Mr. Levenson’s career is his pivotal role in securing funding from the NIH’s RADx initiative to develop a rapid COVID-19 antigen test. This achievement demonstrates his ability to ...

We've identified the following companies as similar to Radiopharm Theranostics Ltd ADR because they operate in a related industry or sector. We also considered size, growth, and various financial ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...

Natural Gas Q1 2025 Price ForecastWed, 01 Jan 2025 14:10:15 GMT Gold (XAU) and Silver (XAG) Q1 2025 Price ForecastWed, 01 Jan 2025 14:32:46 GMT Bitcoin Q1 2025 Price ForecastWed, 01 Jan 2025 14:10 ...